Home > Insider Trading > Filing (0001209191-22-021343)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1441693	Marrone Bio Innovations Inc	MBII	Agricultural Chemicals (2870)	205137161

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1582885	G Pamela Marrone	C/O Marrone Bio Innovations, Inc. 7780-420 Brier Creek Parkway Raleigh NC 27617-7882		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-24	20,000	$0.80	2,243,363	No	4	M	Direct
Common Stock	Disposition	2022-03-24	22,728	$1.11	2,220,635	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Disposition	2022-03-24	20,000	$0.00	20,000	$0.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,320		2026-08-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,442	Indirect	See Footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.10 to $1.13, inclusive. The reporting person undertakes to provide to Marrone Bio Innovations, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.